Navigation Links
New Report Just Published: World Prostate Cancer Therapeutics Market Report
Date:7/7/2009

ter Acquisition II-75 Radiation Therapy Takes Over a North Carolina Treatment Center II-75 DRAXIMAGE and Med Discovery Enter into Research Collaboration II-75 Core Oncology Completes Acquisition of Coloplast's Brachytherapy Business II-76 Novacea Licenses Asenstar Prostate Cancer Drug to Schering-Plough II-76 Bentley Receives Approval for Generic Version of Casodex II-76 GSK Acquires Praecis Pharmaceuticals II-77 Samaritan Acquires Metastatin Pharma II-77 Champions Biotechnology Acquires Patent Rights for Potential Cancer Treatments II-77 GPC Biotech Submits NDA for Treatment of Prostate Cancer II-77 MedMira Inks Agreement to Take Over Rights of a New Marker Technology II-78 Cell Genesys's GVAX Prostate Cancer-Treatment Attains FDA's Fast Track Tag II-78 Envisioneering Medical Enters into Agreement with BrachySciences II-78 Signet Enters into Agreement with AsymmetRx to Distribute 'Prostate-63' Tests II-79 Mylan Pharmaceuticals Obtains FDA Approval for Finasteride's ANDA II-79 Aeterna Zentaris Enters into Agreement with Nippon Kayaku II-79 Progenics Pharmaceuticals Broadens Association with Seattle Genetics II-80 Diosynth and Dendreon Sign Multi-Year Commercial Supply Deal II-80 Genstar Capital Completes Acquisition of OnCure II-80 Generex Biotechnology Expands Antigen Express Cancer Trials II-80 Progenics Pharmaceuticals Acquires PSMA Development Company II-81 Schweizerhall Acquires Novosis II-81 Misonix Expands into France with Sonablate(R) 500 II-81 Indevus Enters into Agreement to Takeover Valera II-82 Oncobionic Receives FDA Clearance for Cancer Treatment Technology II-82 Misonix Expands HIFU Business in Europe by Entering into Spain II-82 Altana Divests Entire Stake in GPC Biotech II-83 Ipsen Enters into Partnership with GTx to Develop and Market Acapodene in Europe II-83 Egenix and Prote
'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 /PRNewswire/ - Aptose Biosciences Inc. ... developing new therapeutics that target the underlying mechanisms of ... Administration (FDA) has granted the company orphan drug designation ... (AML). APTO-253, a first-in-class inducer of the KLF4 gene, ... Ib clinical trial in patients with AML, high-risk myelodysplastic ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... addition of Jain PharmaBiotech,s new report "Biomarkers ... offering. This report follows the broad ... can be objectively measured and evaluated as an ... well as pharmacological responses to a therapeutic intervention. ...
(Date:6/2/2015)... 2015   Y-Prime, Inc ., announced today ... 2015 in Philadelphia , June ... gathering, allows influential decision makers from the Biotech ... evaluate emerging technologies such as YPrime. ... design, implementation and management of Interactive Response Technology ...
(Date:6/2/2015)... , June 2, 2015  RXi ... biotechnology company focused on discovering and developing ... dermatology and ophthalmology, today announced that Dr. ... will present at the 23 rd ... world congress will include in-depth presentations by ...
Breaking Biology Technology:Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 2Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 3YPrime at BIO Exhibition in Philadelphia and DIA in Washington DC during the month of June 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4
... -- Rita Colwell, former director of the National Science ... Health" at 5:30 p.m. Monday, Oct. 3, in a ... Union. , ,Colwell headed the NSF from 1998-2004. She ... a distinguished professor at the University of Maryland and ...
... acquire healthcare information technology provider IDX Systems Corp. ... Thursday. The transaction is expected to close by early ... complementary product lines," said GE Healthcare Vice President Don ... comprehensive product line across radiology systems, across electronic health ...
... -- Third Wave Technologies Inc. , a developer ... analysis applications, is being sued by Belgium-based Innogenetics N.V. ... Meanwhile, in a separate case, Third Wave has won a ... is a provider of diagnostic and therapeutic products, with a ...
Cached Biology Technology:Third Wave sued by one firm; gets injunction against another 2
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
(Date:4/14/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... York Design Awards under the category  ,Product Design – ... Awards are part of a global multi-disciplinary awards program. ... the marketplace, industry and judging panel. Winners will be ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading ... ways to more fully engage with their communities around ... industry-leading, privacy protected and secure API.  ... enables the most accessible, affordable, and convenient vehicle to ... The API will allow ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... / b3c newswire / - Critical Outcome ... today from animal experiments carried out at a prominent ... adds to the already impressive data package for COTI-2, ... with first line therapies with low toxicity in seven ...
... of cancer mortality in children. Even if a cure ... stressful treatment which can be harmful to the developing ... gentle treatment methods. The most important childhood brain tumors ... young patients each year in Germany, and pylocytic astrocytoma, ...
... This release is available in Spanish . ... understand the trophic food chains involving microbian plankton. That is, to ... that live organisms can be classified from the perspective of nutrition. ... these levels are united one to the other, forming a chain. ...
Cached Biology News:ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4University of the Basque Country research on plankton at Urdaibai 2
...
... series offers versatile liquid handling platforms and ... wide variety of life science applications.The Freedom ... sizes (75, 100, 150 and 200 cm), ... platform that will advance with their application ...
... utilizes utilizies CTI Molecular Imaging's proprietary ... resolution, sensitivty, and a large imaging ... flexibility to image multiple mice or ... is a dedicated small animal PET ...
... Diluent (MOPS Buffered) has been developed specifically ... in solution. HRP Stabilizer prevents the ... conformation of the antibody or protein antigen ... filtered at 0.2 microns., ,Contents: Aqueous, ...
Biology Products: